BSM Technologies CEO Aly Rahemtulla. SaaS-based player BSM Technologies (TSX:GPS) is well positioned to gain market share in the fragmented fleet tracking space, says Cantor Fitzgerald Canada analyst Blair Abernethy.
In a research report to clients this morning, Abernethy initiated coverage of BSM with a “Buy” rating and $3.00 one-year target.
Abernethy says the telematics industry has literally hundreds of providers who have struggled in the space because their solutions are largely hardware focused, and they have become commoditized. He says there is now a growing demand for machine-to-machine solutions that collect data and automate manual processes. He thinks the foothold that BSM has gained in the rail sector not only has room left for growth, but could be used as leverage that could complement or augment new verticals.
The Cantor analyst notes that while BSM currently is the dominant player in Canadian rail support, its has been deployed to just 19% of the rail support vehicle fleets here. He expects that number will grow to in excess of 40% over the next two years.
Abernethy says additional growth for BSM can come in the form of new verticals, M&A, and geographic expansion. He cites a report from Berg Insight that says there are 35-million commercial vehicles in North America, an estimated $8.4-billion opportunity. There are currently 12-million storage tanks in the U.S., another potential vertical for BSM.
Valuation-wise, Abernethy says BSM is trading at a mere 2.6x EV/Sales based on his 2015 estimates. Industry comparables, he notes, are trading at 4.1x.
ATB Capital Markets analyst Tim Monachello raised his rating on Questor Technology (Questor Technology Stock Quote, Chart, News, Analysts, Financials… [Read More]
Ventum Capital Markets analyst Amr Ezzat maintained a “Buy” rating and C$47.00 target price for Tecsys (Tecsys Stock Quote, Chart,… [Read More]
Roth Capital Markets analyst Scott Searle maintained a “Buy” rating and US$17.50 target price for Gogo (Gogo Stock Quote, Chart,… [Read More]
Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$12.00 target price on Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock… [Read More]
Paradigm Capital analyst Marvin Wolff maintained a “Buy” rating and $0.55 target price for CHAR Technologies (CHAR Technologies Stock Quote,… [Read More]
Beacon Securities analyst Donangelo Volpe maintained a “Buy” rating and $2.00 target price for Imaflex (Imaflex Stock Quote, Chart, News,… [Read More]